Ellevest Inc’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $390K | Sell |
877
-231
| -21% | -$103K | 0.06% | 251 |
|
|
2025
Q1 | $537K | Sell |
1,108
-546
| -33% | -$265K | 0.04% | 179 |
|
|
2024
Q4 | $666K | Sell |
1,654
-107
| -6% | -$43.1K | 0.04% | 151 |
|
|
2024
Q3 | $819K | Buy |
1,761
+14
| +0.8% | +$6.51K | 0.05% | 132 |
|
|
2024
Q2 | $819K | Buy |
1,747
+65
| +4% | +$30.5K | 0.05% | 123 |
|
|
2024
Q1 | $703K | Sell |
1,682
-7
| -0.4% | -$2.93K | 0.04% | 146 |
|
|
2023
Q4 | $687K | Sell |
1,689
-121
| -7% | -$49.2K | 0.05% | 130 |
|
|
2023
Q3 | $629K | Buy |
1,810
+232
| +15% | +$80.7K | 0.05% | 120 |
|
|
2023
Q2 | $555K | Buy |
1,578
+117
| +8% | +$41.2K | 0.04% | 136 |
|
|
2023
Q1 | $460K | Buy |
1,461
+265
| +22% | +$83.5K | 0.04% | 151 |
|
|
2022
Q4 | $345K | Buy |
1,196
+103
| +9% | +$29.7K | 0.03% | 206 |
|
|
2022
Q3 | $316K | Buy |
1,093
+235
| +27% | +$67.9K | 0.03% | 173 |
|
|
2022
Q2 | $242K | Buy |
858
+645
| +303% | +$182K | 0.02% | 245 |
|
|
2022
Q1 | $56K | Sell |
213
-41
| -16% | -$10.8K | ﹤0.01% | 505 |
|
|
2021
Q4 | $56K | Sell |
254
-1,132
| -82% | -$250K | 0.01% | 489 |
|
|
2021
Q3 | $251K | Sell |
1,386
-71
| -5% | -$12.9K | 0.02% | 232 |
|
|
2021
Q2 | $294K | Buy |
1,457
+271
| +23% | +$54.7K | 0.03% | 177 |
|
|
2021
Q1 | $255K | Buy |
1,186
+215
| +22% | +$46.2K | 0.03% | 163 |
|
|
2020
Q4 | $229K | Buy |
971
+171
| +21% | +$40.3K | 0.03% | 137 |
|
|
2020
Q3 | $218K | Buy |
800
+161
| +25% | +$43.9K | 0.04% | 124 |
|
|
2020
Q2 | $186K | Buy |
639
+307
| +92% | +$89.4K | 0.04% | 121 |
|
|
2020
Q1 | $79K | Buy |
332
+111
| +50% | +$26.4K | 0.02% | 166 |
|
|
2019
Q4 | $48K | Buy |
221
+200
| +952% | +$43.4K | 0.01% | 205 |
|
|
2019
Q3 | $4K | Sell |
21
-10
| -32% | -$1.91K | ﹤0.01% | 287 |
|
|
2019
Q2 | $6K | Buy |
31
+11
| +55% | +$2.13K | ﹤0.01% | 292 |
|
|
2019
Q1 | $4K | Hold |
20
| – | – | ﹤0.01% | 257 |
|
|
2018
Q4 | $3K | Buy |
+20
| New | +$3K | ﹤0.01% | 457 |
|